FDANonrulemakingFDA-2010-N-0477

Who commented on this docket

Biosimilar and Interchangeable Biological Products

2 organizations filed 2 public comments on Biosimilar and Interchangeable Biological Products, at the Food and Drug Administration. The comment window closed 5688d ago.

Organizations
2
Comments
2
RIN
Comment window
closed 5688d ago

Commenters (2)

View this docket on regulations.gov →

Attribution is name-based and imperfect. regulations.gov data is public record.